Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Apr;64(4):1420–1425. doi: 10.1128/iai.64.4.1420-1425.1996

Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors.

F A Sylvester 1, U S Sajjan 1, J F Forstner 1
PMCID: PMC173935  PMID: 8606110

Abstract

Piliated Burkholderia (formerly Pseudomonas) cepacia from sputa of cys tic fibrosis patients in Toronto, Canada, were shown earlier to bind to purified mucins and to a protein receptor on epithelial cells via a 22-kDa adhesin located on unique cable pili. However, a second receptor, thought to be lipid in nature, was also identified on cells and appeared to serve as the major cell receptor for poorly piliated or nonpiliated isolates. In the present study in vitro approaches were used to identify putative lipid receptors for B. cepacia and to explore the nature of the binding interaction. As judged by thin-layer chromatography overlay assays, the best receptors were digalactosylceramide and globotriosylceramide (Gb(3)). Both contain and unsubstituted terminal Gal alpha 1-4Gal sequence. B cepacia also bound moderately to galactosylceramide, gangliotriosylceramide, and gangliotetraosylceramide. Binding to glycolipids was not affected by tetramethylurea, a hydrophobic-bond-breaking adhesin for GB(3). Binding to glycolipids was not affected by tetramethylurea, a hydrophobic-bond-breaking agent. Binding was influenced by the structure of the ceramide, which probably affects the presentation of the agent. Binding was influenced by the structure of the ceramide, which probably affects the presentation of the carbohydrate epitope to the bacteria. Gb(3) was also the major receptor in lipid extracts of human erythrocytes, human buccal epithelial cells and HEp-2 laryngeal epithelial cells. In a receptor-based enzyme-linked immunosorbent assay, binding to Gb(3) within a phospholipid-cholesterol mixture (a membrane-like environment) increased and then approached saturation as a direct function of increasing bacterial concentration. The calculated value of K(a) (3.06 X 10(-8) ml/CFU), the affinity constant, was almost identical to the K(a) calculated earlier for B. cepacia binding to a set of lipid receptors in buccal epithelial cells (1.5 X 10(-8) to 2.0 X 10(-8) ml/CFU). Our findings suggest that within cell membranes, galactose-containing glycolipids, particularly Gb(3) are good candidates for receptors for B. cepacia, particularly for isolates in which cable pili are poorly expressed.

Full Text

The Full Text of this article is available as a PDF (368.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bock K., Breimer M. E., Brignole A., Hansson G. C., Karlsson K. A., Larson G., Leffler H., Samuelsson B. E., Strömberg N., Edén C. S. Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1----4Gal-containing glycosphingolipids. J Biol Chem. 1985 Jul 15;260(14):8545–8551. [PubMed] [Google Scholar]
  2. Deal C. D., Krivan H. C. Lacto- and ganglio-series glycolipids are adhesion receptors for Neisseria gonorrhoeae. J Biol Chem. 1990 Aug 5;265(22):12774–12777. [PubMed] [Google Scholar]
  3. Gold B. D., Huesca M., Sherman P. M., Lingwood C. A. Helicobacter mustelae and Helicobacter pylori bind to common lipid receptors in vitro. Infect Immun. 1993 Jun;61(6):2632–2638. doi: 10.1128/iai.61.6.2632-2638.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goldstein R., Sun L., Jiang R. Z., Sajjan U., Forstner J. F., Campanelli C. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol. 1995 Feb;177(4):1039–1052. doi: 10.1128/jb.177.4.1039-1052.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grant C. W. Model membranes bearing glycolipids and glycoproteins. Chem Phys Lipids. 1986 Jun-Jul;40(2-4):285–302. doi: 10.1016/0009-3084(86)90074-5. [DOI] [PubMed] [Google Scholar]
  6. Greally P., Hussein M. J., Cook A. J., Sampson A. P., Piper P. J., Price J. F. Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. Arch Dis Child. 1993 Mar;68(3):389–392. doi: 10.1136/adc.68.3.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hansson G. C., Karlsson K. A., Larson G., Strömberg N., Thurin J. Carbohydrate-specific adhesion of bacteria to thin-layer chromatograms: a rationalized approach to the study of host cell glycolipid receptors. Anal Biochem. 1985 Apr;146(1):158–163. doi: 10.1016/0003-2697(85)90410-5. [DOI] [PubMed] [Google Scholar]
  8. Iglewski B. H., Sadoff J., Bjorn M. J., Maxwell E. S. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3211–3215. doi: 10.1073/pnas.75.7.3211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  10. Kannagi R., Nudelman E., Hakomori S. Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3470–3474. doi: 10.1073/pnas.79.11.3470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karlsson K. A., Angström J., Bergström J., Lanne B. Microbial interaction with animal cell surface carbohydrates. APMIS Suppl. 1992;27:71–83. [PubMed] [Google Scholar]
  12. Kaye S. A., Louise C. B., Boyd B., Lingwood C. A., Obrig T. G. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro. Infect Immun. 1993 Sep;61(9):3886–3891. doi: 10.1128/iai.61.9.3886-3891.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Krivan H. C., Ginsburg V., Roberts D. D. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2). Arch Biochem Biophys. 1988 Jan;260(1):493–496. doi: 10.1016/0003-9861(88)90473-0. [DOI] [PubMed] [Google Scholar]
  14. Krivan H. C., Nilsson B., Lingwood C. A., Ryu H. Chlamydia trachomatis and Chlamydia pneumoniae bind specifically to phosphatidylethanolamine in HeLa cells and to GalNAc beta 1-4Gal beta 1-4GLC sequences-found in asialo-GM1 and asial-GM2. Biochem Biophys Res Commun. 1991 Mar 29;175(3):1082–1089. doi: 10.1016/0006-291x(91)91676-4. [DOI] [PubMed] [Google Scholar]
  15. Krivan H. C., Roberts D. D., Ginsburg V. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc beta 1-4Gal found in some glycolipids. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6157–6161. doi: 10.1073/pnas.85.16.6157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kuehn M., Lent K., Haas J., Hagenzieker J., Cervin M., Smith A. L. Fimbriation of Pseudomonas cepacia. Infect Immun. 1992 May;60(5):2002–2007. doi: 10.1128/iai.60.5.2002-2007.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lindberg A. A., Brown J. E., Strömberg N., Westling-Ryd M., Schultz J. E., Karlsson K. A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem. 1987 Feb 5;262(4):1779–1785. [PubMed] [Google Scholar]
  18. Lingwood C. A., Cheng M., Krivan H. C., Woods D. Glycolipid receptor binding specificity of exoenzyme S from Pseudomonas aeruginosa. Biochem Biophys Res Commun. 1991 Mar 29;175(3):1076–1081. doi: 10.1016/0006-291x(91)91675-3. [DOI] [PubMed] [Google Scholar]
  19. Lingwood C. A., Huesca M., Kuksis A. The glycerolipid receptor for Helicobacter pylori (and exoenzyme S) is phosphatidylethanolamine. Infect Immun. 1992 Jun;60(6):2470–2474. doi: 10.1128/iai.60.6.2470-2474.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lingwood C. A., Law H., Pellizzari A., Sherman P., Drumm B. Gastric glycerolipid as a receptor for Campylobacter pylori. Lancet. 1989 Jul 29;2(8657):238–241. doi: 10.1016/s0140-6736(89)90428-5. [DOI] [PubMed] [Google Scholar]
  21. Lingwood C. A., Law H., Richardson S., Petric M., Brunton J. L., De Grandis S., Karmali M. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem. 1987 Jun 25;262(18):8834–8839. [PubMed] [Google Scholar]
  22. Lonon M. K., Woods D. E., Straus D. C. Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol. 1988 May;26(5):979–984. doi: 10.1128/jcm.26.5.979-984.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. McKevitt A. I., Bajaksouzian S., Klinger J. D., Woods D. E. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun. 1989 Mar;57(3):771–778. doi: 10.1128/iai.57.3.771-778.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pellizzari A., Pang H., Lingwood C. A. Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochemistry. 1992 Feb 11;31(5):1363–1370. doi: 10.1021/bi00120a011. [DOI] [PubMed] [Google Scholar]
  25. Richman-Eisenstat J. B., Jorens P. G., Hébert C. A., Ueki I., Nadel J. A. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol. 1993 Apr;264(4 Pt 1):L413–L418. doi: 10.1152/ajplung.1993.264.4.L413. [DOI] [PubMed] [Google Scholar]
  26. Saiman L., Cacalano G., Prince A. Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa. Infect Immun. 1990 Aug;58(8):2578–2584. doi: 10.1128/iai.58.8.2578-2584.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Saiman L., Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest. 1993 Oct;92(4):1875–1880. doi: 10.1172/JCI116779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sajjan S. U., Forstner J. F. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun. 1992 Apr;60(4):1434–1440. doi: 10.1128/iai.60.4.1434-1440.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sajjan U. S., Corey M., Karmali M. A., Forstner J. F. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992 Feb;89(2):648–656. doi: 10.1172/JCI115631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sajjan U. S., Forstner J. F. Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun. 1993 Aug;61(8):3157–3163. doi: 10.1128/iai.61.8.3157-3163.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sajjan U. S., Sun L., Goldstein R., Forstner J. F. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol. 1995 Feb;177(4):1030–1038. doi: 10.1128/jb.177.4.1030-1038.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sokol P. A., Lewis C. J., Dennis J. J. Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol. 1992 Mar;36(3):184–189. doi: 10.1099/00222615-36-3-184. [DOI] [PubMed] [Google Scholar]
  33. Staugas R. E., Harvey D. P., Ferrante A., Nandoskar M., Allison A. C. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and IL-1 production in human leukocytes. Infect Immun. 1992 Aug;60(8):3162–3168. doi: 10.1128/iai.60.8.3162-3168.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stein P. E., Boodhoo A., Tyrrell G. J., Brunton J. L., Read R. J. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature. 1992 Feb 20;355(6362):748–750. doi: 10.1038/355748a0. [DOI] [PubMed] [Google Scholar]
  35. Steinbach S., Sun L., Jiang R. Z., Flume P., Gilligan P., Egan T. M., Goldstein R. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med. 1994 Oct 13;331(15):981–987. doi: 10.1056/NEJM199410133311504. [DOI] [PubMed] [Google Scholar]
  36. Strömberg N., Nyholm P. G., Pascher I., Normark S. Saccharide orientation at the cell surface affects glycolipid receptor function. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9340–9344. doi: 10.1073/pnas.88.20.9340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sun L., Jiang R. Z., Steinbach S., Holmes A., Campanelli C., Forstner J., Sajjan U., Tan Y., Riley M., Goldstein R. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med. 1995 Jul;1(7):661–666. doi: 10.1038/nm0795-661. [DOI] [PubMed] [Google Scholar]
  38. Tablan O. C., Chorba T. L., Schidlow D. V., White J. W., Hardy K. A., Gilligan P. H., Morgan W. M., Carson L. A., Martone W. J., Jason J. M. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985 Sep;107(3):382–387. doi: 10.1016/s0022-3476(85)80511-4. [DOI] [PubMed] [Google Scholar]
  39. Tyrrell G. J., Ramotar K., Toye B., Boyd B., Lingwood C. A., Brunton J. L. Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):524–528. doi: 10.1073/pnas.89.2.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Vance D. E., Sweeley C. C. Quantitative determination of the neutral glycosyl ceramides in human blood. J Lipid Res. 1967 Nov;8(6):621–630. [PubMed] [Google Scholar]
  41. Yiu S. C., Lingwood C. A. Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures. Anal Biochem. 1992 Apr;202(1):188–192. doi: 10.1016/0003-2697(92)90226-w. [DOI] [PubMed] [Google Scholar]
  42. van de Kar N. C., Monnens L. A., Karmali M. A., van Hinsbergh V. W. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood. 1992 Dec 1;80(11):2755–2764. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES